EL SEGUNDO, Calif., May 4 /PRNewswire-FirstCall/ -- DaVita Inc. (NYSE: DVA) announced that the United States Attorney's Office for the Eastern District of New York has informed the company that it has completed its investigation without taking any action against the company. The company was first issued a formal subpoena in October 2004 and fully cooperated with the investigation. No charges were made against the company, no fines were assessed and no mandatory policy changes were required in connection with this investigation. (Logo http://www.newscom.com/cgi-bin/prnh/20020729/DAVITALOGO ) "We are pleased that the government, after a lengthy and thorough review, has decided to close this broad investigation into our business practices. We are proud of our culture of regulatory compliance at DaVita," said Chairman and CEO Kent Thiry. DaVita Inc. is a leading provider of kidney care in the United States, providing dialysis services and education for patients with chronic kidney failure and end stage renal disease. DaVita manages more than 1,400 outpatient facilities and acute units in more than 700 hospitals located in 43 states and the District of Columbia, serving approximately 110,000 patients. http://www.newscom.com/cgi-bin/prnh/20020729/DAVITALOGO http://photoarchive.ap.org/ DATASOURCE: DaVita Inc. CONTACT: LeAnne Zumwalt, Investor Relations of DaVita Inc., +1-650-696-8910 Web Site: http://www.davita.com/

Copyright